Boldenone Undecylenate, 500mg (1 vial)

Mechanism of medicine action:

Boldenone Undecylenate 500 mg/mL enhances protein synthesis and red blood cell production, improving oxygen transport and nutrient delivery. This makes it effective for cutting cycles and contest preparation, as it promotes endurance and metabolic efficiency with reduced caloric intake.

Carcinogenesis:

There are rare reports of hepatocellular carcinoma in patients receiving long-term, high-dose androgen therapy. In some cases, withdrawal of the drug did not lead to tumor regression. Older patients may face increased risk of prostatic hypertrophy or carcinoma, although conclusive evidence is limited.

Dosage:

Male users typically administer 300–800 mg per week for 8–20 weeks depending on goals, while female users may take 50–100 mg per week to achieve gains with minimized side effects. Beginners should start at the lower range. A structured dosage plan reduces the risk of complications.

Injection Site Care & Technique:

To ensure safe and comfortable administration of injectable products:

• Warm the vial to body temperature before use
• Use a sterile 25G–27G needle and syringe
• Inject slowly into the muscle to minimize tissue irritation
• Massage the area gently after injection
• Rotate injection sites regularly
• Avoid injecting into inflamed or previously used areas
• Store product upright and avoid excessive agitation

Why Are There Crystals in Boldenone Undecylenate 500mg/mL?

Crystallization is a natural property of Boldenone Undecylenate at high concentrations and does not indicate contamination. Fluctuations in temperature during transport or storage may trigger crystal formation in 500mg/mL formulations.

Safe & Effective Solution:

To resolve crystallization, apply dry heat using a seed mat, heating pad, or incubator at 60–70°C (140–160°F) for 30–60 minutes. Avoid water baths to minimize contamination risk. Shake thoroughly until the solution is clear. Store at a stable room temperature or warmer.

Critical Safety Warning:

Do not inject if crystals remain in the solution. This may result in abscesses, tissue damage, or infection. Crystallization is common in highly concentrated compounds. For increased solubility and long-term stability, consider using lower concentrations such as 300mg/mL or 400mg/mL.

Crystallization Notice:

Crystallization is a natural property of Boldenone Undecylenate, particularly in high concentrations (500mg/mL),
and may occur due to temperature changes during shipping or storage. This is a normal physical reaction and
not a sign of product defect or contamination.

If Crystallization Occurs:

-Apply gentle dry heat (using a heating pad or seed mat) at 60-70°C / 140-160°F for 30-60 minutes

-Shake the vial vigorously until the solution is completely clear

-To prevent recurrence, store at a stable, warm room temperature

Important Safety Warning:

Never inject the solution if any crystals remain. Injecting undissolved crystals can cause
tissue injury, infection, or abscess.

Note: The 500mg/mL concentration is more susceptible to crystallization. For users seeking a less crystallization-prone option, our 300mg/mL version provides enhanced solubility and stability.

Prescription-only medication. Administer under licensed medical supervision.